Skip to main content

Articles

Page 4 of 76

  1. Colorectal cancer (CRC) is one of the most common malignant cancers worldwide and seriously threatens human health. The clustered regulatory interspaced short palindromic repeat/CRISPR-associate nuclease 9 (CR...

    Authors: Yang Hu, Liang Liu, Qi Jiang, Weiping Fang, Yazhu Chen, Yuntian Hong and Xiang Zhai
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:308
  2. Authors: Jian-Xian Lin, Xin-Sheng Xie, Xiong-Feng Weng, Sheng-Liang Qiu, Changhwan Yoon, Ning-Zi Lian, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ying-Hong Yang, Chang-Ming Huang, Chao-Hui Zheng…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:307

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:410

  3. Liver metastasis is one of the most important reasons for high mortality of colorectal cancer (CRC). Growing evidence illustrates that lncRNAs play a critical role in CRC liver metastasis. Here we described a ...

    Authors: Xidi Wang, Yu Liu, Miao Zhou, Lei Yu and Zizhen Si
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:306
  4. Authors: Nianshuang Li, Yan Feng, Yi Hu, Cong He, Chuan Xie, Yaobin Ouyang, Stephen C. Artim, Deqiang Huang, Yin Zhu, Zhijun Luo, Zhongming Ge and Nonghua Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:305

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:280

  5. Diffuse pleural mesothelioma (DPM) is an aggressive therapy-resistant cancer with unique molecular features. Numerous agents have been tested, but clinically effective ones remain elusive. Herein, we propose t...

    Authors: Anand Singh, Nathanael Pruett, Shivani Dixit, Sudheer K. Gara, Haitao Wang, Roma Pahwa, David S. Schrump and Chuong D. Hoang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:304
  6. Despite remarkable advancements in cancer immunotherapy, the overall response rate to anti-programmed cell death-1 (anti-PD-1) therapy in hepatocellular carcinoma (HCC) patients remains low. Our previous study...

    Authors: Jialiang Wang, Xiaoyu Zhang, Xinyi Ma, Dongmei Chen, Meina Cai, Lexin Xiao, Jing Li, Zexuan Huang, Yuehua Huang and Yifan Lian
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:303
  7. Understanding the mechanism behind immune cell plasticity in cancer metastasis is crucial for identifying key regulators. Previously we found that mitotic factors regulate epithelial-mesenchymal transition, bu...

    Authors: Rong Xu, Young-Joo Lee, Chang-Hyeon Kim, Ga-Hong Min, Yeo-Bin Kim, Jung-Won Park, Dae-Hoon Kim, Jung-Hyun Kim and Hyungshin Yim
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:302
  8. Inherited defects in the base-excision repair gene MBD4 predispose individuals to adenomatous polyposis and colorectal cancer, which is characterized by an accumulation of C > T transitions resulting from spon...

    Authors: Christophe Papin, Abdulkhaleg Ibrahim, Jamal S. M. Sabir, Stéphanie Le Gras, Isabelle Stoll, Raed S. Albiheyri, Ali T. Zari, Ahmed Bahieldin, Alfonso Bellacosa, Christian Bronner and Ali Hamiche
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:301
  9. Epirubicin/cyclophosphamide (EC) and docetaxel (D) are commonly used in a sequential regimen in the neoadjuvant treatment of early, high-risk or locally advanced breast cancer (BC). Novel approaches to increas...

    Authors: Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:300
  10. Gastric-cancer is a heterogeneous type of neoplastic disease and it lacks appropriate therapeutic options. There is an urgent need for the development of innovative pharmacological strategies, particularly in ...

    Authors: Luca Guarrera, Mami Kurosaki, Silvio-Ken Garattini, Maurizio Gianni’, Gianpiero Fasola, Luca Rossit, Michele Prisciandaro, Maria Di Bartolomeo, Marco Bolis, Paola Rizzo, Claudia Nastasi, Marika Foglia, Adriana Zanetti, Gabriela Paroni, Mineko Terao and Enrico Garattini
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:298
  11. The Hippo pathway is crucial in organ size control and tumorigenesis. Dysregulation of the Hippo/YAP axis is commonly observed in gastric cancer, while effective therapeutic targets for the Hippo/YAP axis are ...

    Authors: Tianshi Wang, Dehai Wang, Yanan Sun, Ting Zhuang, Xin Li, Huijie Yang, Yifeng Zang, Ziping Liu, Penghe Yang, Chenmiao Zhang, Jiayao Cui, Mingxi Fu, Shuqing Zhang, Peng Su, Zhongbo Li, Jian Zhu…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:297
  12. Long noncoding RNAs (lncRNAs) have been reported to play vital roles in the development and progression of cancer. However, their biological significance and functional mechanisms in non-small cell lung cancer...

    Authors: Li Zhang, Jingtian Liang, Hao Qin, Yin Lv, Xiucheng Liu, Zhuoqun Li, Zhixiang Chao, Caili Jia, Xichun Qin and Hao Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:296
  13. Ovarian cancer is commonly associated with a poor prognosis due to metastasis and chemoresistance. PINK1 (PTEN-induced kinase 1) is a serine/threonine kinase that plays a crucial part in regulating various physio...

    Authors: Fang Zheng, Jiamin Zhong, Kelie Chen, Yu Shi, Fang Wang, Shengchao Wang, Song Tang, Xiaoyu Yuan, Zhangjin Shen, Sangsang Tang, Dajing Xia, Yihua Wu and Weiguo Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:295
  14. The tumor microenvironment (TME) is an important factor that regulates the progression of colorectal cancer (CRC). Cancer-associated fibroblasts (CAFs) are the main mesenchymal cells in the TME and play a vita...

    Authors: Shenghe Deng, Denglong Cheng, Jun Wang, Junnan Gu, Yifan Xue, Zhenxing Jiang, Le Qin, Fuwei Mao, Yinghao Cao and Kailin Cai
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:294
  15. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood, whose prognosis is still poor especially for metastatic, high-grade, and relapsed RMS. New treatments are urgently needed, especially...

    Authors: Andrea Timpanaro, Caroline Piccand, Dzhangar Dzhumashev, Stenija Anton-Joseph, Andrea Robbi, Janine Moser, Jochen Rössler and Michele Bernasconi
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:293
  16. Triple-negative breast cancer (TNBC) is characterized by aggressive growth and a high propensity for recurrence and metastasis. Simultaneous overexpression of c-MET and EGFR in TNBC is associated with worse cl...

    Authors: Seongjae Kim, Jung Min Park, Soeun Park, Eunsun Jung, Dongmi Ko, Minsu Park, Juyeon Seo, Kee Dal Nam, Yong Koo Kang, Kyoungmin Lee, Lee Farrand, Yoon-Jae Kim, Ji Young Kim and Jae Hong Seo
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:292
  17. Metabolic reprogramming of amino acids has been increasingly recognized to initiate and fuel tumorigenesis and survival. Therefore, there is emerging interest in the application of amino acid metabolic strateg...

    Authors: Yue Zheng, Yiran Yao, Tongxin Ge, Shengfang Ge, Renbing Jia, Xin Song and Ai Zhuang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:291
  18. Invasion and metastasis are the main causes of unfavourable prognosis in patients diagnosed with bladder cancer. The efficacy of immunotherapy in bladder cancer remains suboptimal due to the presence of an imm...

    Authors: Wei-Min Hu, Ming Li, Jin-Zhuo Ning, Yu-Qi Tang, Tian-Bao Song, Lin-Zhi Li, Fan Zou, Fan Cheng and Wei-Min Yu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:290
  19. TAMs (tumor-associated macrophages) infiltration promotes the progression of esophageal cancer (EC). However, the underlying mechanisms remain unclear.

    Authors: Xinwei Qiao, Zaixing Cheng, Kaming Xue, Cui Xiong, Zhikun Zheng, Xin Jin and Jinsong Li
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:289
  20. Hepatocellular carcinoma (HCC) accounts for a majority of primary liver cancer cases and related deaths. The purpose of this study was to assess the diagnostic value of splicing factor 3b subunit 4 (SF3B4) as ...

    Authors: Ju A Son, Ji Hyang Weon, Geum Ok Baek, Hye Ri Ahn, Ji Yi Choi, Moon Gyeong Yoon, Hyo Jung Cho, Jae Youn Cheong, Jung Woo Eun and Soon Sun Kim
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:288
  21. Immune checkpoint blockade (ICB) has significantly prolonged survival of non-small cell lung cancer (NSCLC) patients, although most patients develop mechanisms of resistance. Recently single-cell RNA-sequencin...

    Authors: Belinda Palermo, Ornella Franzese, Giuseppe Frisullo, Lorenzo D’Ambrosio, Mariangela Panetta, Giulia Campo, Daniel D’Andrea, Isabella Sperduti, Francesca De Nicola, Frauke Goeman, Filippo Gallina, Paolo Visca, Francesco Facciolo and Paola Nisticò
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:287
  22. The endoplasmic reticulum (ER) regulates critical processes, including lipid synthesis, which are affected by transmembrane proteins localized in the ER membrane. One such protein, transmembrane protein 147 (T...

    Authors: Jingjing Huang, Huayang Pan, Jing Sun, Jiaming Wu, Qiyue Xuan, Jinge Wang, Shanjia Ke, Shounan Lu, Zihao Li, Zhigang Feng, Yongliang Hua, Qingan Yu, Bing Yin, Baolin Qian, Menghua Zhou, Yanan Xu…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:286
  23. Temozolomide (TMZ) treatment efficacy in glioblastoma (GBM) patients has been limited by resistance in the clinic. Currently, there are no clinically proven therapeutic options available to restore TMZ treatme...

    Authors: Shanqiang Qu, Songtao Qi, Huayang Zhang, Zhiyong Li, Kaicheng Wang, Taichen Zhu, Rongxu Ye, Wanghao Zhang, Guanglong Huang and Guo-zhong Yi
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:285

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:314

  24. Oncolytic viruses are now well recognized as potential immunotherapeutic agents against cancer. However, the first FDA-approved oncolytic herpes simplex virus 1 (HSV-1), T-VEC, showed limited benefits in some ...

    Authors: Guosong Wang, Jiali Cao, Mengxuan Gui, Pengfei Huang, Liang Zhang, Ruoyao Qi, Ruiqi Chen, Lina Lin, Qiangyuan Han, Yanhua Lin, Tian Chen, Peiqing He, Jian Ma, Rao Fu, Junping Hong, Qian Wu…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:284

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:312

  25. Lung cancer is the most common and deadliest cancer worldwide, and approximately 90% of all lung cancer deaths are caused by tumor metastasis. Tumor-derived exosomes could potentially promote tumor metastasis ...

    Authors: Xiu-Rui Hsu, Jia-En Wu, Yi-Ying Wu, Sheng-Yen Hsiao, Jui-Lin Liang, Ya-Ju Wu, Chia-Hao Tung, Meng-Fan Huang, Ming-Shiu Lin, Pan-Chyr Yang, Yuh-Ling Chen and Tse-Ming Hong
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:283
  26. Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, mainly due to its late diagnosis and lack of effective therapies, translating into a low 5-year 12% survival rate, desp...

    Authors: Emilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, María Trinidad Moreno-Montilla, Víctor García-Vioque, Inmaculada Berbel, Raúl M. Luque, Bruno Sainz Jr, Alejandro Ibáñez-Costa and Justo P. Castaño
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:282
  27. Patient Derived Organoids (PDOs) emerged as the best technology to develop ex vivo tumor avatars. Whether drug testing on PDOs to identify efficient therapies will bring clinical utility by improving patient s...

    Authors: Jérôme Cartry, Sabrina Bedja, Alice Boilève, Jacques R. R. Mathieu, Emilie Gontran, Maxime Annereau, Bastien Job, Ali Mouawia, Pierre Mathias, Thierry De Baère, Antoine Italiano, Benjamin Besse, Isabelle Sourrouille, Maximiliano Gelli, Mohamed-Amine Bani, Peggy Dartigues…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:281
  28. Pancreatic cancer is one of the most common causes of cancer-related death, and the 5-year survival rate has only improved marginally over the last decade. Late detection of the disease means that in most case...

    Authors: Nicole L. Wittwer, Michael P. Brown, Vasilios Liapis and Alexander H. Staudacher
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:280
  29. Cancer recurrence is regulated by a variety of factors, among which is the material of dying tumor cells; it is suggested that remaining after anti-cancer therapy tumor cells receive a signal from proteins cal...

    Authors: Dmitry V. Sverchinsky, Bashar A. Alhasan, Marina A. Mikeladze, Vladimir F. Lazarev, Liubov S. Kuznetcova, Alisa V. Morshneva, Alina D. Nikotina, Amr Ziewanah, Lidia V. Koludarova, Tatiana Y. Starkova, Boris A. Margulis and Irina V. Guzhova
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:279
  30. Authors: Livia Ronchetti, Irene Terrenato, Margherita Ferretti, Giacomo Corrado, Frauke Goeman, Sara Donzelli, Chiara Mandoj, Roberta Merola, Ashanti Zampa, Mariantonia Carosi, Giovanni Blandino, Laura Conti, Anna Maria Lobascio, Marcello Iacobelli, Enrico Vizza, Giulia Piaggio…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:278

    The original article was published in Journal of Experimental & Clinical Cancer Research 2022 41:151

  31. Tumor cell-induced platelet aggregation (TCIPA) is not only a recognized mechanism for paraneoplastic thrombocytosis but also a potential breakthrough alternative for a low response to immune checkpoint inhibi...

    Authors: Yuyi Chen, Jie Zhou, Zishen Liu, Tongtong Wu, Shumeng Li, Yutong Zhang, Xiaohui Yin, Guowang Yang and Ganlin Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:277
  32. Immune-checkpoint inhibitors (ICI) can lead to immune-related adverse events (irAEs) in a significant proportion of patients. The mechanisms underlying irAEs development are mostly unknown and might involve mu...

    Authors: Sofia Genta, Katherine Lajkosz, Noelle R. Yee, Pavlina Spiliopoulou, Alya Heirali, Aaron R. Hansen, Lillian L. Siu, Sam Saibil, Lee-Anne Stayner, Maryia Yanekina, Maxwell B. Sauder, Sareh Keshavarzi, Abdulazeez Salawu, Olga Vornicova, Marcus O. Butler, Philippe L. Bedard…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:276
  33. Alterations in several tripartite motif-containing (TRIM) family proteins have been implicated in the pathogenesis of lung cancer. TRIM28, a member of the TRIM E3 ligase family, has been associated with tumori...

    Authors: Manman Liang, Zhengui Sun, Xingwu Chen, Lijing Wang, Hanli Wang, Lilong Qin, Wenying Zhao and Biao Geng
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:275
  34. Tumor cells can resist chemotherapy-induced pyroptosis through glycolytic reprogramming. Estrogen-related receptor alpha (ERRα) is a central regulator of cellular energy metabolism associated with poor cancer ...

    Authors: Pingping Su, Xiaodan Mao, Jincheng Ma, Lixiang Huang, Lirui Yu, Shuting Tang, Mingzhi Zhuang, Zhonglei Lu, Kelvin Stefan Osafo, Yuan Ren, Xinrui Wang, Xite Lin, Leyi Huang, Xiaoli Huang, Elena Ioana Braicu, Jalid Sehouli…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:274
  35. The insulin-like growth factor receptor (IGF-1R) was among the most intensively pursued kinase targets in oncology. However, even after a slew of small-molecule and antibody therapeutics reached clinical trial...

    Authors: Upendra K. Soni, Liam Jenny and Rashmi S. Hegde
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:273
  36. Immunotherapy has significantly advanced cancer treatments, but many patients do not respond to it, partly due to immunosuppressive mechanisms used by tumor cells. These cells employ immunosuppressive ligands ...

    Authors: Dong-hee Lee, Hyejin Ahn, Hye-In Sim, Eunji Choi, Seunghyun Choi, Yunju Jo, Bohwan Yun, Hyun Kyu Song, Soo Jin Oh, Kaori Denda-Nagai, Chan-Sik Park, Tatsuro Irimura, Yoon Park and Hyung-seung Jin
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:272
  37. Authors: Jie Shen, Beibei Cao, Yatao Wang, Chenshen Ma, Zhuo Zeng, Liang Liu, Xiaolan Li, Deding Tao, Jianping Gong and Daxing Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:271

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:175

  38. Epithelial ovarian cancer (EOC) is a global health burden, with the poorest five-year survival rate of the gynecological malignancies due to diagnosis at advanced stage and high recurrence rate. Recurrence in ...

    Authors: Brittney S. Harrington, Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lidia F. Hernandez, Donna Butcher, Elijah F. Edmondson, Nadia Traficante, Joy Hendley, Madeline Gough, Rebecca Rogers, Rohan Lourie, Jyoti Shetty, Bao Tran, Fathi Elloumi…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:270
  39. Important roles of INHBB in various malignancies are increasingly identified. The underlying mechanisms in gastric cancer (GC) microenvironment are still greatly unexplored.

    Authors: Yangbing Jin, Qu Cai, Lingquan Wang, Jun Ji, Ying Sun, Jinling Jiang, Chao Wang, Junwei Wu, Benyan Zhang, Liqin Zhao, Feng Qi, Beiqin Yu and Jun Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:269
  40. Dysregulated epithelial–mesenchymal transition (EMT) is involved in cervical cancer metastasis and associated with histone acetylation. However, the underlying molecular mechanisms of histone acetylation in ce...

    Authors: Xiaohui Yang, Fei Sun, Yueying Gao, MengYongwei Li, Mian Liu, Yunjian Wei, Qiuling Jie, Yibing Wang, Jiaoqi Mei, Jingjing Mei, Linna Ma, Yuechuan Shi, Manling Chen, Yongsheng Li, Qi Li, Mingyao Liu…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:268
  41. Long non-coding RNAs (LncRNAs) have been extensively studied to play essential roles in tumor progression. However, more in-depth studies are waiting to be solved on how lncRNAs regulate the progression of hep...

    Authors: Fan Wang, Yuhang Hu, Hongda Wang, Ping Hu, Hewei Xiong, Zhu Zeng, Shengbo Han, Decai Wang, Jie Wang, Yong Zhao, Yan Huang, Wenfeng Zhuo, Guozheng Lv and Gang Zhao
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:267
  42. Authors: Xiaomei Gao, Yuanyuan Sheng, Jing Yang, Chaoqun Wang, Rui Zhang, Ying Zhu, Ze Zhang, Kaili Zhang, Shican Yan, Haoting Sun, Jinwang Wei, Xuan Wang, Xinxin Yu, Yu Zhang, Qin Luo, Yan Zheng…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:266

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:179

  43. Spindle and kinetochore-associated complex subunit 3 (SKA3) plays an important role in cell proliferation by regulating the separation of chromosomes and their division into daughter cells. Previous studies de...

    Authors: Yananlan Chen, Xiao Xu, Yirui Wang, Yaodong Zhang, Tao Zhou, Wangjie Jiang, Ziyi Wang, Jiang Chang, Shuochen Liu, Ruixiang Chen, Jijun Shan, Jifei Wang, Yuming Wang, Changxian Li and Xiangcheng Li
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:265
  44. Disseminated tumor cells (DTCs) can enter a dormant state and cause no symptoms in cancer patients. On the other hand, the dormant DTCs can reactivate and cause metastases progression and lethal relapses. In p...

    Authors: Ruihua Liu, Shang Su, Jing Xing, Ke Liu, Yawei Zhao, Mary Stangis, Diego P. Jacho, Eda D. Yildirim-Ayan, Cara M. Gatto-Weis, Bin Chen and Xiaohong Li
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:264
  45. RNA N6-Methyladenosine (m6A) modification is implicated in the progression of human cancers including cholangiocarcinoma (CCA). METTL16 is recently identified as a new RNA methyltransferase responsible for m6A...

    Authors: Nianli Liu, Jinqiang Zhang, Weina Chen, Wenbo Ma and Tong Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:263
  46. Pancreatitis is known to be an important risk factor for pancreatic ductal adenocarcinoma (PDAC). However, the exact molecular mechanisms of how inflammation promotes PDAC are still not fully understood. Regna...

    Authors: Junya Okabe, Takahiro Kodama, Yu Sato, Satoshi Shigeno, Takayuki Matsumae, Kazuma Daiku, Katsuhiko Sato, Teppei Yoshioka, Minoru Shigekawa, Masaya Higashiguchi, Shogo Kobayashi, Hayato Hikita, Tomohide Tatsumi, Toru Okamoto, Takashi Satoh, Hidetoshi Eguchi…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:262
  47. Epstein-Barr virus (EBV) is the first discovered human tumor virus that is associated with a variety of malignancies of both lymphoid and epithelial origin including nasopharyngeal carcinoma (NPC). The EBV-enc...

    Authors: Chaoliang Liao, Min Li, Xue Chen, Chenpeng Tang, Jing Quan, Ann M. Bode, Ya Cao and Xiangjian Luo
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:261
  48. In the era of personalized medicine, the establishment of preclinical models of cancer that faithfully recapitulate original tumors is essential to potentially guide clinical decisions.

    Authors: Lucie Thorel, Pierre-Marie Morice, Hippolyte Paysant, Romane Florent, Guillaume Babin, Cécilia Thomine, Marion Perréard, Edwige Abeilard, Florence Giffard, Emilie Brotin, Christophe Denoyelle, Céline Villenet, Shéhérazade Sebda, Mélanie Briand, Florence Joly, Enora Dolivet…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:260
  49. Acute myeloid leukemia (AML) is a malignant blood cancer with marked cellular heterogeneity due to altered maturation and differentiation of myeloid blasts, the possible causes of which are transcriptional or ...

    Authors: Edoardo Peroni, Maria Luigia Randi, Antonio Rosato and Stefano Cagnin
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:259

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions